Molecular characterization of breast cancer CTCs associated with brain metastasis

Debasish Boral; Monika Vishnoi; Haowen N. Liu; Wei Yin; Marc L. Sprouse; Antonio Scamardo; David S. Hong; Tuan Z. Tan; Jean P. Thiery; Jenny C. Chang; Dario Marchetti

doi:10.1038/s41467-017-00196-1

Molecular characterization of breast cancer CTCs associated with brain metastasis

Debasish Boral, Monika Vishnoi, Haowen N. Liu, Wei Yin, Marc L. Sprouse, Antonio Scamardo, David S. Hong, Tuan Z. Tan, Jean P. Thiery, Jenny C. Chang, Dario Marchetti

Research output: Contribution to journal › Article › peer-review

152 Scopus citations

Abstract

The enumeration of EpCAM-positive circulating tumor cells (CTCs) has allowed estimation of overall metastatic burden in breast cancer patients. However, a thorough understanding of CTCs associated with breast cancer brain metastasis (BCBM) is necessary for early identification and evaluation of treatment response to BCBM. Here we report that BCBM CTCs is enriched in a distinct sub-population of cells identifiable by their biomarker expression and mutational content. Deriving from a comprehensive analysis of CTC transcriptomes, we discovered a unique “circulating tumor cell gene signature” that is distinct from primary breast cancer tissues. Further dissection of the circulating tumor cell gene signature identified signaling pathways associated with BCBM CTCs that may have roles in potentiating BCBM. This study proposes CTC biomarkers and signaling pathways implicated in BCBM that may be used either as a screening tool for brain micro-metastasis detection or for making rational treatment decisions and monitoring therapeutic response in patients with BCBM.

Original language	English (US)
Article number	196
Number of pages	31
Journal	Nature Communications
Volume	8
Issue number	1
Early online date	Aug 4 2017
DOIs	https://doi.org/10.1038/s41467-017-00196-1
State	Published - Dec 1 2017

Keywords

Breast cancer
Metastasis

ASJC Scopus subject areas

Chemistry(all)
Biochemistry, Genetics and Molecular Biology(all)
Physics and Astronomy(all)

Access to Document

10.1038/s41467-017-00196-1

Cite this

@article{8615168370074700b68bf5e335ec6563,

title = "Molecular characterization of breast cancer CTCs associated with brain metastasis",

abstract = "The enumeration of EpCAM-positive circulating tumor cells (CTCs) has allowed estimation of overall metastatic burden in breast cancer patients. However, a thorough understanding of CTCs associated with breast cancer brain metastasis (BCBM) is necessary for early identification and evaluation of treatment response to BCBM. Here we report that BCBM CTCs is enriched in a distinct sub-population of cells identifiable by their biomarker expression and mutational content. Deriving from a comprehensive analysis of CTC transcriptomes, we discovered a unique “circulating tumor cell gene signature” that is distinct from primary breast cancer tissues. Further dissection of the circulating tumor cell gene signature identified signaling pathways associated with BCBM CTCs that may have roles in potentiating BCBM. This study proposes CTC biomarkers and signaling pathways implicated in BCBM that may be used either as a screening tool for brain micro-metastasis detection or for making rational treatment decisions and monitoring therapeutic response in patients with BCBM.",

keywords = "Breast cancer, Metastasis",

author = "Debasish Boral and Monika Vishnoi and Liu, {Haowen N.} and Wei Yin and Sprouse, {Marc L.} and Antonio Scamardo and Hong, {David S.} and Tan, {Tuan Z.} and Thiery, {Jean P.} and Chang, {Jenny C.} and Dario Marchetti",

year = "2017",

month = dec,

day = "1",

doi = "10.1038/s41467-017-00196-1",

language = "English (US)",

volume = "8",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Molecular characterization of breast cancer CTCs associated with brain metastasis

AU - Boral, Debasish

AU - Vishnoi, Monika

AU - Liu, Haowen N.

AU - Yin, Wei

AU - Sprouse, Marc L.

AU - Scamardo, Antonio

AU - Hong, David S.

AU - Tan, Tuan Z.

AU - Thiery, Jean P.

AU - Chang, Jenny C.

AU - Marchetti, Dario

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The enumeration of EpCAM-positive circulating tumor cells (CTCs) has allowed estimation of overall metastatic burden in breast cancer patients. However, a thorough understanding of CTCs associated with breast cancer brain metastasis (BCBM) is necessary for early identification and evaluation of treatment response to BCBM. Here we report that BCBM CTCs is enriched in a distinct sub-population of cells identifiable by their biomarker expression and mutational content. Deriving from a comprehensive analysis of CTC transcriptomes, we discovered a unique “circulating tumor cell gene signature” that is distinct from primary breast cancer tissues. Further dissection of the circulating tumor cell gene signature identified signaling pathways associated with BCBM CTCs that may have roles in potentiating BCBM. This study proposes CTC biomarkers and signaling pathways implicated in BCBM that may be used either as a screening tool for brain micro-metastasis detection or for making rational treatment decisions and monitoring therapeutic response in patients with BCBM.

AB - The enumeration of EpCAM-positive circulating tumor cells (CTCs) has allowed estimation of overall metastatic burden in breast cancer patients. However, a thorough understanding of CTCs associated with breast cancer brain metastasis (BCBM) is necessary for early identification and evaluation of treatment response to BCBM. Here we report that BCBM CTCs is enriched in a distinct sub-population of cells identifiable by their biomarker expression and mutational content. Deriving from a comprehensive analysis of CTC transcriptomes, we discovered a unique “circulating tumor cell gene signature” that is distinct from primary breast cancer tissues. Further dissection of the circulating tumor cell gene signature identified signaling pathways associated with BCBM CTCs that may have roles in potentiating BCBM. This study proposes CTC biomarkers and signaling pathways implicated in BCBM that may be used either as a screening tool for brain micro-metastasis detection or for making rational treatment decisions and monitoring therapeutic response in patients with BCBM.

KW - Breast cancer

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=85026742061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026742061&partnerID=8YFLogxK

U2 - 10.1038/s41467-017-00196-1

DO - 10.1038/s41467-017-00196-1

M3 - Article

C2 - 28775303

SN - 2041-1723

VL - 8

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 196

ER -

Molecular characterization of breast cancer CTCs associated with brain metastasis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this